Analyst consensus rating
Ocular Therapeutix Analyst Rating: Strong Buy
Direct answer
Ocular Therapeutix's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $26.00.
Forecast evidence checked October 19, 2026.
Get free Ocular Therapeutix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.87
- Average price target
- $26.00
- High price target
- $34.00
- Low price target
- $14.00
- Low target gap
- +103.8%
- Target upside
- +278.5%
- High target gap
- +394.9%
- Target range width
- 291.1%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ocular Therapeutix?
Ocular Therapeutix has a verified Strong Buy consensus. The same dataset has an average price target of $26.00.
How far are Ocular Therapeutix's low and high targets from the recorded price?
The low target implies +103.8%, while the high target implies +394.9%.
How many analysts are included in Ocular Therapeutix's consensus?
The verified consensus includes 12 analysts.
How is Ocular Therapeutix's target upside or downside calculated?
The average target of $26.00 is divided by the recorded price of $6.87, then one is subtracted to produce +278.5%. This does not guarantee a future return.
When was Ocular Therapeutix's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.